High Prevalence of Growth Hormone Deficiency in Severe Fibromyalgia Syndromes | Zendy

Guillem Cuatrecasas | Zendy; Michael J. González | Zendy; C. Alegre | Zendy; Gemma Sesmilo | Zendy; Joaquim FernándezSolà | Zendy; Felipe F. Casanueva | Zendy; Ferran J Garcia-Fructuoso | Zendy; Violant PocaDias | Zendy; J. P. Izquierdo | Zendy; Manel PuigDomingo | Zendy

AI Assistant Blog Pricing

Open Access

High Prevalence of Growth Hormone Deficiency in Severe Fibromyalgia Syndromes

Author(s) -

Guillem Cuatrecasas,

Michael J. González,

C. Alegre,

Gemma Sesmilo,

Joaquim FernándezSolà,

Felipe F. Casanueva,

Ferran J Garcia-Fructuoso,

Violant PocaDias,

J. P. Izquierdo,

Manel PuigDomingo

Publication year - 2010

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2010-0061

Subject(s) - fibromyalgia , context (archaeology) , medicine , quality of life (healthcare) , physical therapy , hormone , growth hormone , physical medicine and rehabilitation , pediatrics , biology , paleontology , nursing

Fibromyalgia (FM) is characterized by widespread pain and fatigue and is considered a syndrome with different pathogenic mechanisms. Controversial data on GH axis disturbances have been published. Some preliminary trials have shown promising effects of GH therapy on tender points and quality of life in FM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog